In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
about
Combinatorial approaches to the prevention and treatment of HIV-1 infectionIn vitro activity of caspofungin against Candida albicans biofilms.Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case reportTreatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy.Aspergillus infections in transplant recipients.Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.Metabolism and resistance of Fusarium spp. to the manzamine alkaloids via a putative retro pictet-spengler reaction and utility of the rational design of antimalarial and antifungal agents.Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspofungin and itraconazole.In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results.Current treatment options for chronic granulomatous disease.New methods to assess susceptibilities of Aspergillus isolates to caspofungin.Antifungal pharmacotherapy for invasive mould infections.The first echinocandin: caspofungin.Caspofungin: first approved agent in a new class of antifungals.Systemic antifungal therapy: new options, new challenges.Infections caused by Fusarium species.New and emerging antifungal agents: impact on respiratory infections.Management of infectious complications in the hematopoietic stem cell transplant recipient.Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patientsConcentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.Combating infections in hematopoietic stem cell transplant recipients.New developments in antifungal strategy.Combination treatment of invasive fungal infections.Caspofungin: an overview.Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitroEchinocandin antifungals: review and update.Emerging echinocandins for treatment of invasive fungal infections.In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreusIn vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeuticsCombination antifungal therapy: the new frontier.A comparative evaluation of properties and clinical efficacy of the echinocandins.Combination therapeutic approaches for the management of invasive aspergillosis in organ transplant recipients.Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesAntifungal therapies in the intensive care unit.
P2860
Q30400060-7E3425A6-7D08-4462-B3A5-F7C3827A9784Q31114513-31AB1C2C-81BC-48B7-96E0-2CA9017E0E3BQ33188045-73F4A8F6-213F-436D-B359-41FC3A945AB1Q33284273-64BAE8E7-986B-4D12-90B9-E622DF3BC45FQ33292907-DE066E7B-ACEA-4D30-ADEB-62FAB42C06D0Q33719294-E542749E-2935-4DDF-AD6D-33D5CFF5D935Q33805542-FB3D4F5B-7811-41DB-BEDB-7D010465BAE9Q33857685-097451A4-11E3-428A-A2FA-5894E17D0C02Q33938075-DDADA571-DD91-4F9A-9C05-A79BB1283214Q34069955-15566C43-F698-493D-B020-761D97EDD0EDQ34125983-E310B611-A9F3-4F90-BC36-C8AE81C2CB93Q34144184-F9E75B73-73EE-4750-A392-ACF439D04DC1Q34706880-89B899E1-2D52-41BB-8CE5-1E3CDF064F83Q34956645-78593155-40E9-4CBC-BFFB-F8575AA18844Q35058091-6A1D74F0-031B-46DA-9036-39E540405A8FQ35105398-4027F43F-300D-4335-AC49-F97C59FE484DQ35124726-31AC4C7B-5CB0-4340-9A55-58E06F64E975Q35585219-E523D654-5FEC-48B3-AE97-52ECBEEEECDFQ35622021-8743EA2F-CD69-4748-89F2-2A886C54504CQ35627629-FAE18577-19ED-4F5C-9452-482921F34878Q35675979-6D9069A6-2B8A-4FFE-9195-797C9F222657Q35799730-8D5A7309-53E5-4A67-940A-146A973CE04DQ35840760-AC1AF795-274D-4A6E-B38C-34E27CA73579Q35870651-11754EEF-3232-4C2D-A146-0BF1A134F63AQ35878130-B57D88E9-11DC-4713-9B8C-080930F96293Q35917135-11F128F9-9E0D-4C21-AAA5-E7C528B29051Q35917388-D9BB3CD0-B4C6-4FE5-8328-3A02D13DF5ADQ36011378-98AAC103-30E7-45C2-AFB4-6CAAA62319DEQ36278031-6D88E74E-9B7E-4578-83F4-3A4FF1567528Q36396105-0F637935-79E1-4D03-B919-9FCA05D3C4CAQ36441524-92CCB003-0638-48F9-8B5E-F3EC27AC71FFQ36458402-87C24D4E-5766-43E8-971B-89BD280D868EQ36492208-AA8AA355-113E-404F-91F6-1E68BE0154A6Q36558484-DD1B540F-3A54-4EB4-B2F8-5FB6A8692C5CQ36866689-2B2AE798-5631-47FE-8E68-7C2F0434ECC3Q36895652-56D0A4DC-EEBA-4BFA-825B-4E039241762BQ36895839-8DAE507B-419A-4F81-872B-A02BDD34EAAFQ37078394-727053BF-1363-4744-9776-9FF0599EF182Q37157546-2AFCE0F3-662C-462E-A34C-EC6108F29FD7Q37161793-A405092B-A302-4FAD-A3D7-930EA7E1B73B
P2860
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
@en
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
@nl
type
label
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
@en
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
@nl
prefLabel
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
@en
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
@nl
P2093
P2860
P1476
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
@en
P2093
John H Rex
Mario Lozano-Chiu
Sevtap Arikan
Victor Paetznick
P2860
P304
P356
10.1128/AAC.46.1.245-247.2002
P407
P577
2002-01-01T00:00:00Z